Feuerstein Not Excited About JPMorgan Biotech Conference

JPMorgan's Annual Healthcare Conference is one of the largest gathering of healthcare companies, executives, investors, and other stakeholders and kicks off on Monday.

Chris Lewis of Roth Capital Partners commented in a note on January 5 that he is expecting "a number of preannouncments" within the space. The analyst added that many companies are expected to issue preliminary fourth quarter 2015 results and/or 2016 guidance Monday morning.

Meanwhile, The Street's Adam Feuerstein, a notable biotech expert, thinks the sector's outlook is dire. On January 7, Feuerstein tweeted that 2016 will be a "bummer year" for biotech stocks.

Here are some of Feuerstein's other notable Tweets expressing his bearish outlook for the sector.

Today and Monday are my favorite days of year b/c 75% of table-setting PRs from biotech cos. read like this: pic.twitter.com/AoMrQbAUJN

— Adam Feuerstein (@adamfeuerstein) January 8, 2016

My #JPM16 calendar is not full (with co. meetings.) Because meeting with you to hear your spin-laden PR spiel is a waste of my time.

— Adam Feuerstein (@adamfeuerstein) January 8, 2016

If I win Powerball tonight, I'm still attending #JPM16, except I'll be much happier.

— Adam Feuerstein (@adamfeuerstein) January 9, 2016